- Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye conditionon June 11, 2025 at 6:00 pm
Novo Nordisk's drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC's Disruptor 50 List.
- RFK Jr.'s firing of CDC vaccine panel undermines science, could threaten public health, experts sayon June 10, 2025 at 6:55 pm
Some experts say the move undermines science, disrupts a trusted regulatory process and could sow public distrust in vaccinations and federal health agencies.
- What's next for Oura Ring in personal health and fitness monitoring, according to CEO Tom Haleon June 10, 2025 at 5:27 pm
Oura has leaned further into providing wearers of its eponymous connected ring with a fuller picture of overall health and wellness.
- RFK Jr. removes all members of CDC panel advising U.S. on vaccineson June 10, 2025 at 3:21 pm
It's the latest move by Kennedy – a prominent vaccine skeptic – to change and potentially undermine vaccinations in the U.S. since he took the helm at HHS.
- FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZenecaon June 9, 2025 at 8:13 pm
Merck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
- Omada shares rise 21% in Nasdaq debut after health tech company's IPOon June 6, 2025 at 8:18 pm
Omada Health became the latest tech company to hit the Nasdaq on Friday, as the IPO market picks up steam.
- Omada Health prices IPO at $19 per share, in middle of expected rangeon June 6, 2025 at 11:33 am
Omada Health is set to start trading on the Nasdaq, hitting the market a few weeks after Hinge Health, another emerging company in the space.